| Date Filed | Type | Description |
| 06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/14/2023 |
4
| Wengel Kathryn E (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Exercised 742 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| Wengel Kathryn E (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 849 restricted stock units
@ $0 |
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2022 |
4
| Wengel Kathryn E (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Exercised 603 restricted stock units
@ $0 |
|
| 02/17/2022 |
4
| Wengel Kathryn E (EVP, Chief GSC Officer) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Paid exercise price by delivering 4,699 shares
@ $165.89, valued at
$779.5k
Granted 30,214 options to buy
@ $165.89, valued at
$5M
Granted 1,530 options to buy
@ $0
Exercised 10,386 options to buy
@ $0 |
|
| 02/15/2022 |
4
| Wengel Kathryn E (EVP, Chief GSC Officer) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Paid exercise price by delivering 695 shares
@ $168.85, valued at
$117.4k
Exercised 1,896 options to buy
@ $0 |
|
| 02/15/2022 |
4
| Wengel Kathryn E (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 742 restricted stock units
@ $0 |
|
| 03/29/2021 |
4
| Wengel Kathryn E (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 603 restricted stock units
@ $0 |
|
| 03/29/2021 |
3/A
| Wengel Kathryn E (Director) has filed a Form 3/A on LABORATORY CORP OF AMERICA HOLDINGS |
| 03/26/2021 |
3
| Wengel Kathryn E (Director) has filed a Form 3 on LABORATORY CORP OF AMERICA HOLDINGS |
| 02/17/2021 |
4
| Wengel Kathryn E (EVP, Chief GSC Officer) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Paid exercise price by delivering 618 shares
@ $165.55, valued at
$102.3k
Paid exercise price by delivering 3,796 shares
@ $165.55, valued at
$628.4k
Exercised 8,704 options to buy
@ $0
Exercised 1,658 options to buy
@ $0 |
|
| 09/04/2020 |
4
| Wengel Kathryn E (EVP, Chief GSC Officer) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Sold 7,877 shares
@ $153.508, valued at
$1.2M
Sold 8,238 shares
@ $153.527, valued at
$1.3M
Exercised 8,238 options to buy
@ $62.2, valued at
$512.4k
Exercised 7,877 options to buy
@ $65.37, valued at
$514.9k
|
|
| 02/18/2020 |
4
| Wengel Kathryn E (EVP, Chief GSC Officer) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Paid exercise price by delivering 2,909 shares
@ $150.46, valued at
$437.7k
Paid exercise price by delivering 4,203 shares
@ $150.46, valued at
$632.4k
Exercised 8,217 options to buy
@ $0
Exercised 7,592 options to buy
@ $0 |
|
| 02/12/2020 |
4
| Wengel Kathryn E (EVP, Chief GSC Officer) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Granted 46,210 options to buy
@ $151.41, valued at
$7M
Granted 8,217 options to buy
@ $0
Granted 1,807 options to buy
@ $0 |
|
| 12/16/2019 |
4
| Wengel Kathryn E (EVP, Chief GSC Officer) has filed a Form 4 on JOHNSON & JOHNSON|
Txns:
| Sold 2,017 shares
@ $141.07, valued at
$284.5k
Exercised 2,017 options to buy
@ $62.62, valued at
$126.3k
|
|
| 12/16/2019 |
3/A
| Wengel Kathryn E (EVP, Chief GSC Officer) has filed a Form 3/A on JOHNSON & JOHNSON |
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2018 |
3
| Wengel Kathryn E (EVP, Chief GSC Officer) has filed a Form 3 on JOHNSON & JOHNSON |